IL33 and systemic lupus erythematosus: In rheumatoid arthritis as well as lupus patients, increased serum levels of IL-33 have been shown to correlate with autoantibody levels, including anti-Sjögren's syndrome type B, rheumatoid factor, anti-citrullinated antibodies, among others (29, 61, 62).